". Subjects were blinded as to which method was used. All patients received 20 units of BT in the glabellar region (Botox, Allergan, Irvine, CA). Follow-up photographs and DISC analysis were completed weekly for the first month, then monthly up to six months post-injection. The Facial Lines Outcome 11-item survey (FLO-11) survey was also administered at each follow-up. After 6 months, subjects were crossed over and were re-injected utilizing the other method. Follow-up for the second injection was the same as the first. Statistical comparison was completed via matched sample T-test.
PURPOSE:
Evidence suggests that incision management with negative-pressure therapy (ciNPT) may provide clinical benefit in various surgical applications such as orthopedic, sternotomy, abdominal wall repairs, colorectal procedures by protecting surgical incisions and removing fluid and infectious materials. This study compares postoperative outcomes including complication rates and drain use among patients using ciNPT* versus standard of care (SOC) after breast reconstruction.
METHODS:
This single-site, retrospective cohort study included data for breast reconstruction procedures from October 1, 2013 -March 31, 2016. Data collected included demographics, chemotherapy/radiation exposure, surgical technique, ciNPT use, number of drains, total drain duration, and 90 day post-operative complication rates. Two-sided T-test and Chi-square or Fisher's Exact tests were performed at α=0.05.
RESULTS:
The study included data on 155 patients (ciNPT=64, SOC=91) and 294 breasts (ciNPT=125, SOC=169). There were no significant differences in mean age, BMI, proportion of smokers and patients with hypertension between the two groups. The ciNPT group had a lower proportion of patients that had prior breast surgery and radiation exposure. There were no significant differences in chemotherapy exposure before 1 st stage of reconstruction but ciNPT group had lower percentage of patients who had chemotherapy exposure after 1 st stage of reconstruction. More patients in the ciNPT group underwent a pre-pectoral technique of breast reconstruction compared to the control group. Complication rates were examined at the breast level. The overall complication rate was 7 (5.6%) in the ciNPT group compared to 24 (14.2%) in the SOC group (p=0.0176). Significant differences were found in the infection rates [0(0%) v. 10(5.9%)], rates of dehiscence [0(0%) v. 11(6.5%)], rates of necrosis [1(0.8%) v. 16(9.5%) and returns to the OR [0(0%) v. 11(6.5%)] when comparing the ciNPT and SOC groups respectively. All patients in the ciNPT group had 2 drains compared to 81.7% of the Soc group (p<0.0001). The ciNPT group had significantly lower mean drain days per-drain (6.1 vs. 9, p<0.0001) and total drain days (12.2 vs. 18.1, p<0.0001) compared to SOC group. 
METHODS:
A prospective, randomized, double-blinded, placebo-controlled, clinical trial was conducted in which patients undergoing immediate tissue expander/implant based breast reconstruction were randomized to either: 1) intraoperative intercostal and pectoral nerve blocks with 0.25 % bupivacaine with 1:200,000 epinephrine and 4 mg dexamethasone or 2) sham nerve blocks with normal saline. The surgeon, patient and researchers collecting postoperative data were blind to group allocation. Quality of recovery (QoR 40), pain score, and opioid use in the postoperative period were compared between groups using the Mann-Whitney's U test. Fisher's exact test was used between categorical variables. RESULTS: 45 total subjects were enrolled. There were no statistically significant differences in quality of recovery, pain burden, or opioid consumption between groups at 24 hours following surgery. The difference in overall QoR 40 score approached clinical significance, and data trended towards reduced total opioid consumption and better pain control in PACU in the treatment group.
1 Both groups had a good quality of recovery. There were no injection-related complications.
CONCLUSIONS:
Intraoperative nerve blocks can be a safe and effective adjunct to a comprehensive regimen to improve quality of recovery and pain control following tissue expander/implant breast reconstruction. (SSIR) . Often in the case of LVOS, reduction mammaplasty designs are used in the oncoplastic reconstructions with a contralateral symmetry operation. The goal of this study was to investigate the cost-utility between LVOS versus SSIR to determine which approach is cost-effective in the treatment of breast cancer. There has been no previous cost nor clinical effectiveness analysis comparing these techniques.
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METHODS:
A review of the literature was performed to calculate probabilities for clinical outcomes for each surgical option (LVOS versus SSIR), and to obtain utility scores that were converted into quality adjusted life years (QALYs) as measures for clinical effectiveness. For a cost assessment pertaining to outcomes in each surgical option, average national Medicare payment rates using DRG and CPT codes were used. Radiation was assumed as adjuvant treatment in the LVOS arm. A decision analysis tree was constructed comparing LVOS to SSIR into which these probabilities, QALYs and costs were placed. An incremental cost-utility ratio (ICUR) was calculated comparing the difference for both surgical options in costs by the difference in clinical-effectiveness to see which surgical option was more cost-effective. To validate our results, we performed one-way sensitivity analyses in addition to a Monte-Carlo analysis.
